Foreign-Trade Zone (FTZ) 76-Bridgeport, Connecticut; Notification of Proposed Production Activity; MannKind Corporation (Inhalable Insulin); Danbury, Connecticut, 70751-70752 [2015-29241]

Download as PDF Federal Register / Vol. 80, No. 220 / Monday, November 16, 2015 / Notices contacting the person listed in the section titled FOR FURTHER INFORMATION CONTACT. All reasonable accommodation requests are managed on a case by case basis. John P. Allen, Forest Supervisor, Deschutes National Forest. [FR Doc. 2015–28926 Filed 11–13–15; 8:45 am] BILLING CODE 3411–15–P DEPARTMENT OF COMMERCE Census Bureau Generic Clearance for Questionnaire Pretesting Research U.S. Census Bureau, Commerce. ACTION: Notice. AGENCY: The Department of Commerce, as part of its continuing effort to reduce paperwork and respondent burden, invites the general public and other Federal agencies to take this opportunity to comment on proposed and/or continuing information collections, as required by the Paperwork Reduction Act of 1995, Public Law 104–13 (44 U.S.C. 3506(c)(2)(A)). SUMMARY: To ensure consideration, written comments must be submitted on or before January 15, 2016. ADDRESSES: Direct all written comments to Jennifer Jessup, Departmental Paperwork Clearance Officer, Department of Commerce, Room 6616, 14th and Constitution Avenue NW., Washington, DC 20230 (or via the Internet at jjessup@doc.gov). FOR FURTHER INFORMATION CONTACT: Requests for additional information or copies of the information collection instrument(s) and instructions should be directed to Jennifer Hunter Childs, U.S. Census Bureau, 4600 Silver Hill Road, Washington, DC 20233–9150, (202) 603–4827 (or via the Internet at jennifer.hunter.childs@census.gov). SUPPLEMENTARY INFORMATION: DATES: tkelley on DSK3SPTVN1PROD with NOTICES I. Abstract The Census Bureau plans to request an extension of the current OMB approval to conduct a variety of smallscale questionnaire pretesting activities under this generic clearance. A block of hours will be dedicated to these activities for each of the next three years. OMB will be informed in writing of the purpose and scope of each of these activities, as well as the time frame and the number of burden hours used. The number of hours used will VerDate Sep<11>2014 19:47 Nov 13, 2015 Jkt 238001 not exceed the number set aside for this purpose. This research program will be used by the Census Bureau and survey sponsors to improve questionnaires and procedures, reduce respondent burden, and ultimately increase the quality of data collected in the Census Bureau censuses and surveys. The clearance will be used to conduct pretesting of decennial, demographic, and economic census and survey questionnaires prior to fielding them. Pretesting activities will involve one of the following methods for identifying measurement problems with the questionnaire or survey procedure: Cognitive interviews, focus groups, respondent debriefing, behavior coding of respondent/ interviewer interaction, and split panel tests. II. Method of Collection Any of the following methods may be used: Mail, telephone, face-to-face; paper-and-pencil, CATI, CAPI, Internet, or IVR. III. Data OMB Control Number: 0607–0725. Form Number: Various. Type of Review: Regular submission. Affected Public: Individuals or households, businesses or other for profit, farms. Estimated Number of Respondents: 5,500 per year. Estimated Time per Response: 1 hour. Estimated Total Annual Burden Hours: 5,500 hours annually. Estimated Total Annual Cost to Public: There is no cost to the respondent other than time to answer the information request. Respondents Obligation: Voluntary. Legal Authority: Data collection for this project is authorized under the authorizing legislation for the questionnaire being tested. This may be Title 13, Sections 131, 141, 161, 181, 182, 193, and 301 for Census Bureausponsored surveys, and Title 13 and 15 for surveys sponsored by other Federal agencies. We do not now know what other titles will be referenced, since we do not know what survey questionnaires will be pretested during the course of the clearance. IV. Request for Comments Comments are invited on: (a) Whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information shall have practical utility; (b) the accuracy of the agency’s estimate of the burden (including hours and cost) of the proposed collection of information; (c) PO 00000 Frm 00005 Fmt 4703 Sfmt 4703 70751 ways to enhance the quality, utility, and clarity of the information to be collected; and (d) ways to minimize the burden of the collection of information on respondents, including through the use of automated collection techniques or other forms of information technology. Comments submitted in response to this notice will be summarized and/or included in the request for OMB approval of this information collection; they also will become a matter of public record. Dated: November 10, 2015. Glenna Mickelson, Management Analyst, Office of the Chief Information Officer. [FR Doc. 2015–28929 Filed 11–13–15; 8:45 am] BILLING CODE 3510–07–P DEPARTMENT OF COMMERCE Foreign-Trade Zones Board [B–75–2015] Foreign-Trade Zone (FTZ) 76— Bridgeport, Connecticut; Notification of Proposed Production Activity; MannKind Corporation (Inhalable Insulin); Danbury, Connecticut MannKind Corporation (MannKind), an operator of FTZ 76, submitted a notification of proposed production activity to the FTZ Board for its facilities in Danbury, Connecticut, within FTZ 76. The notification conforming to the requirements of the regulations of the FTZ Board (15 CFR 400.22) was received on October 29, 2015. A separate application for subzone designation at the MannKind facilities was submitted and will be processed under Section 400.31 of the FTZ Board’s regulations (Doc. S–147–2015). The facilities are used for the production of inhalable insulin. Pursuant to 15 CFR 400.14(b), FTZ activity would be limited to the specific foreign-status material and specific finished product described in the submitted notification (as described below) and subsequently authorized by the FTZ Board. Production under FTZ procedures could exempt MannKind from customs duty payments on the foreign-status ingredient used in export production. On its domestic sales, MannKind would be able to choose the duty rate during customs entry procedures that applies to inhalable insulin (duty-free) for the foreign-status ingredient, fumaryl diketopiperazone (duty rate—6.5%). Customs duties also could possibly be deferred or reduced on foreign-status production equipment. E:\FR\FM\16NON1.SGM 16NON1 70752 Federal Register / Vol. 80, No. 220 / Monday, November 16, 2015 / Notices Public comment is invited from interested parties. Submissions shall be addressed to the FTZ Board’s Executive Secretary at the address below. The closing period for their receipt is December 28, 2015. A copy of the notification will be available for public inspection at the Office of the Executive Secretary, Foreign-Trade Zones Board, Room 21013, U.S. Department of Commerce, 1401 Constitution Avenue NW., Washington, DC 20230–0002, and in the ‘‘Reading Room’’ section of the FTZ Board’s Web site, which is accessible via www.trade.gov/ftz. For further information, contact Diane Finver at Diane.Finver@trade.gov or (202) 482–1367. Dated: November 9, 2015. Elizabeth Whiteman, Acting Executive Secretary. [FR Doc. 2015–29241 Filed 11–13–15; 8:45 am] BILLING CODE 3510–DS–P DEPARTMENT OF COMMERCE Foreign-Trade Zones Board [B–45–2015] Foreign-Trade Zone (FTZ) 277— Western Maricopa County, Arizona; Authorization of Production Activity; The Cookson Company, Inc. (Rolling Steel Doors); Goodyear, Arizona tkelley on DSK3SPTVN1PROD with NOTICES On July 13, 2015, The Cookson Company, Inc. submitted a notification of proposed production activity to the Foreign-Trade Zones (FTZ) Board for its facility within FTZ 277—Site 11, in Goodyear, Arizona. The notification was processed in accordance with the regulations of the FTZ Board (15 CFR part 400), including notice in the Federal Register inviting public comment (80 FR 42789, July 20, 2015). The FTZ Board has determined that no further review of the activity is warranted at this time. The production activity described in the notification is authorized, subject to the FTZ Act and the FTZ Board’s regulations, including Section 400.14. Dated: November 10, 2015. Elizabeth Whiteman, Acting Executive Secretary. [FR Doc. 2015–29250 Filed 11–13–15; 8:45 am] BILLING CODE 3510–DS–P VerDate Sep<11>2014 19:47 Nov 13, 2015 Jkt 238001 DEPARTMENT OF COMMERCE Foreign-Trade Zones Board Dated: November 9, 2015. Elizabeth Whiteman, Acting Executive Secretary. [FR Doc. 2015–29237 Filed 11–13–15; 8:45 am] [S–151–2015] BILLING CODE 3510–DS–P Foreign-Trade Zone 119—Minneapolis/ St. Paul, Minnesota; Application for Subzone; CNH Industrial America LLC; Benson, Minnesota An application has been submitted to the Foreign-Trade Zones (FTZ) Board by the Greater Metropolitan Area Foreign Trade Zone Commission, grantee of FTZ 119, requesting subzone status for the facilities of CNH Industrial America LLC in Benson, Minnesota. The application was submitted pursuant to the provisions of the Foreign-Trade Zones Act, as amended (19 U.S.C. 81a– 81u), and the regulations of the FTZ Board (15 CFR part 400). It was formally docketed on November 9, 2015. The proposed subzone would consist of the following sites: Site 1 (25.26 acres)—Benson Plant, 260 Highway 12 SE., Benson; Site 2 (4.01 acres)—Benson Plant Warehouse, 140 30th Avenue SE., Benson; and, Site 3 (1.47 acres)— Benson Northstar, 2200 Tatges Avenue, Benson. The proposed subzone would be subject to the existing activation limit of FTZ 119. A notification of proposed production activity has been submitted and is being processed under 15 CFR 400.37 (Doc. B–61–2015). In accordance with the FTZ Board’s regulations, Camille Evans of the FTZ Staff is designated examiner to review the application and make recommendations to the Executive Secretary. Public comment is invited from interested parties. Submissions shall be addressed to the FTZ Board’s Executive Secretary at the address below. The closing period for their receipt is December 28, 2015. Rebuttal comments in response to material submitted during the foregoing period may be submitted during the subsequent 15-day period to January 11, 2016. A copy of the application will be available for public inspection at the Office of the Executive Secretary, Foreign-Trade Zones Board, Room 21013, U.S. Department of Commerce, 1401 Constitution Avenue NW., Washington, DC 20230–0002, and in the ‘‘Reading Room’’ section of the FTZ Board’s Web site, which is accessible via www.trade.gov/ftz. For further information, contact Camille Evans at Camille.Evans@ trade.gov or (202) 482–2350. PO 00000 Frm 00006 Fmt 4703 Sfmt 4703 DEPARTMENT OF COMMERCE Bureau of Industry and Security [Docket No. 151022984–5984–01] Impact of the Implementation of the Chemical Weapons Convention (CWC) on Legitimate Commercial Chemical, Biotechnology, and Pharmaceutical Activities Involving ‘‘Schedule 1’’ Chemicals (Including Schedule 1 Chemicals Produced as Intermediates) Through Calendar Year 2015 Bureau of Industry and Security, Commerce. ACTION: Notice of inquiry. AGENCY: The Bureau of Industry and Security (BIS) is seeking public comments on the impact that implementation of the Chemical Weapons Convention (CWC), through the Chemical Weapons Convention Implementation Act (CWCIA) and the Chemical Weapons Convention Regulations (CWCR), has had on commercial activities involving ‘‘Schedule 1’’ chemicals during calendar year 2015. The purpose of this notice of inquiry is to collect information to assist BIS in its preparation of the annual certification to the Congress on whether the legitimate commercial activities and interests of chemical, biotechnology, and pharmaceutical firms are being harmed by such implementation. This certification is required under Condition 9 of Senate Resolution 75, April 24, 1997, in which the Senate gave its advice and consent to the ratification of the CWC. DATES: Comments must be received by December 16, 2015. ADDRESSES: You may submit comments by any of the following methods (please refer to RIN 0694–XC028 in all comments and in the subject line of email comments): • Federal rulemaking portal (https:// www.regulations.gov)—you can find this notice by searching on its regulations.gov docket number, which is BIS–2015–0039; • Email: willard.fisher@bis.doc.gov— include the phrase ‘‘Schedule 1 Notice of Inquiry’’ in the subject line; • Fax: (202) 482–3355 (Attn: Willard Fisher); • By mail or delivery to Regulatory Policy Division, Bureau of Industry and SUMMARY: E:\FR\FM\16NON1.SGM 16NON1

Agencies

[Federal Register Volume 80, Number 220 (Monday, November 16, 2015)]
[Notices]
[Pages 70751-70752]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-29241]


-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE

Foreign-Trade Zones Board

[B-75-2015]


Foreign-Trade Zone (FTZ) 76--Bridgeport, Connecticut; 
Notification of Proposed Production Activity; MannKind Corporation 
(Inhalable Insulin); Danbury, Connecticut

    MannKind Corporation (MannKind), an operator of FTZ 76, submitted a 
notification of proposed production activity to the FTZ Board for its 
facilities in Danbury, Connecticut, within FTZ 76. The notification 
conforming to the requirements of the regulations of the FTZ Board (15 
CFR 400.22) was received on October 29, 2015.
    A separate application for subzone designation at the MannKind 
facilities was submitted and will be processed under Section 400.31 of 
the FTZ Board's regulations (Doc. S-147-2015). The facilities are used 
for the production of inhalable insulin. Pursuant to 15 CFR 400.14(b), 
FTZ activity would be limited to the specific foreign-status material 
and specific finished product described in the submitted notification 
(as described below) and subsequently authorized by the FTZ Board.
    Production under FTZ procedures could exempt MannKind from customs 
duty payments on the foreign-status ingredient used in export 
production. On its domestic sales, MannKind would be able to choose the 
duty rate during customs entry procedures that applies to inhalable 
insulin (duty-free) for the foreign-status ingredient, fumaryl 
diketopiperazone (duty rate--6.5%). Customs duties also could possibly 
be deferred or reduced on foreign-status production equipment.


[[Page 70752]]

Public comment is invited from interested parties. Submissions shall be 
addressed to the FTZ Board's Executive Secretary at the address below. 
The closing period for their receipt is December 28, 2015.
    A copy of the notification will be available for public inspection 
at the Office of the Executive Secretary, Foreign-Trade Zones Board, 
Room 21013, U.S. Department of Commerce, 1401 Constitution Avenue NW., 
Washington, DC 20230-0002, and in the ``Reading Room'' section of the 
FTZ Board's Web site, which is accessible via www.trade.gov/ftz.
    For further information, contact Diane Finver at 
Diane.Finver@trade.gov or (202) 482-1367.

    Dated: November 9, 2015.
Elizabeth Whiteman,
Acting Executive Secretary.
[FR Doc. 2015-29241 Filed 11-13-15; 8:45 am]
BILLING CODE 3510-DS-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.